about
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancerGlutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.The induction of the apoptosis of cancer cell by sonodynamic therapy: a review.Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors.E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancerBioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer.Angiogenesis in epithelian ovarian cancer.Clinical uses of tumor markers: a critical review.If the Mountain Does Not Come to Mohammad: The Significance of Guest Operations for Early Stage Ovarian CancerPaclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients.Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk.Hereditary breast-ovarian cancer syndrome in Russia.The incidence of cancers among second-generation Irish living in England and Wales.Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary.Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancersIndividuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancerFactors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies.Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancerDiet and ovarian cancer risk: a case-control study in China.Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.Use of Biomarkers in Screening for Cancer.BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients.
P2860
Q24648770-ACF6EC8D-F53B-4339-83F1-BD6E14321FFAQ27853038-A438C43C-D8BE-41E0-A79F-8730F9C8D3E9Q30458879-0331B59E-8655-49B3-974B-640C8FC1D549Q33397152-4BE682FE-E447-4B80-B3F2-8D6F799D450BQ33533979-85F64000-E7B5-4A9C-9D0A-DDE5F256A124Q33891573-7F336188-19FC-4DF1-83AC-31C0DF76396EQ33919078-1FF5A453-ECD7-4E23-9ACF-902E4A3D3878Q34307441-E1FBA9F0-8E3F-4FB6-B7B5-AA7ADE409076Q34360602-D7872AE5-5278-4BF4-A467-AB44C7388854Q35591181-F0251B7D-ECAC-4293-92F1-A15B81BDC37EQ35933841-BF5968D0-0E60-436D-B116-72C674D41FDFQ35944416-EC89BE79-92DD-4772-B63D-8E3D98C22B16Q36115476-3B25B62F-2B57-4A12-A068-50F7C59D405FQ36292913-1459F12E-9259-4F77-AAD0-92253A1C9641Q36356952-ED2BF5D9-9384-452E-B2DC-22B5826E7269Q36387788-522470B5-03E8-49BD-91B5-A869F4E4A5CAQ36612301-6607F6EA-2F45-4299-B715-AF2C17569336Q36623452-47BB0B5E-7EB3-4D75-B034-FE14ABB28767Q36644247-B58E31DC-3BC4-4048-9711-C22F92DAE92FQ36809577-A07B7E3A-5812-488A-A5C6-1AB01F8D01C7Q37155019-27123015-866E-4C2F-B858-91DC10F06603Q37287558-F6230B3F-A339-4D76-8275-DAB880B42173Q37530604-30E1EDA1-B0F4-455A-9C79-3254DD1976D8Q40287396-96EF29A3-1864-4C56-8B87-DC4FD0F16A99Q40553784-FBDFD02E-4B8E-442C-80CB-B9ED5F8EAC3DQ47132946-D2309A68-CDC1-44EF-A2D3-31E4FF7AA913
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Epithelial ovarian carcinoma.
@en
type
label
Epithelial ovarian carcinoma.
@en
prefLabel
Epithelial ovarian carcinoma.
@en
P1433
P1476
Epithelial ovarian carcinoma.
@en
P2093
G B Kristensen
P304
P356
10.1016/S0140-6736(96)06071-0
P407
P577
1997-01-01T00:00:00Z